TRVI R&D Expense Growth
Trevi Therapeutics Inc · R&D Expense Growth
TRVI R&D Expense Growth
Latest reported-14.98%period ending
TRVI FY R&D Growth (YoY) (0.00% → -14.98%)
Latest values, visible window
High-resolution chart · PNG
TRVI r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -14.9808% | |
| 66.2669% | |
| 19.4061% | |
| -13.7052% | |
| 2.938% | |
| 15.4558% | |
| 37.4289% | |
| 130.8778% | |
| -11.8328% | |
| 0% |